Crossmark

Impacto de dapagliflozina en los factores de riesgo cardiovascular. Más allá del control de la glucemia

Crossref DOI link: https://doi.org/10.1016/j.semerg.2021.09.009

Published Print: 2021-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pallarés, V.

Escobar, C.

Egocheaga, I.

Obaya, J.C.
License Information

Text and Data Mining valid from 2021-12-01
More Information

This article is maintained by: Elsevier

Article Title: Impacto de dapagliflozina en los factores de riesgo cardiovascular. Más allá del control de la glucemia

Journal Title: Medicina de Familia. SEMERGEN

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.semerg.2021.09.009

Content Type: article

Copyright: © 2021 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. All rights reserved.